Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00124137 · ClinicalTrials.gov registry record · NA
Ultrafiltration Versus Intravenous (IV) Diuretics for Patients Hospitalized for Acute Decompensated Heart Failure: (UNLOAD)
A NA study, sponsored by Nuwellis.
- Completed
- Registry status
- NA
- Development phase
- 200
- Enrollment target
NCT00124137 is a NA study that has completed, run by Nuwellis. The registered enrollment target is 200 participants.
The verdict
NCT00124137, a NA study, has completed, sponsored by Nuwellis.
- COMPLETED
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
Study Summary
The purpose of this study is to compare patients who are suffering from heart failure and who are fluid overloaded to determine if ultrafiltration (UF) can remove more of the extra fluid as measured by weight loss while in the hospital and improve the patient's breathing.
Interventions
- DEVICE Aquadex system
- DRUG IV diuretic
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2004-04 |
| Est. Completion | 2005-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00124137
The ClinicalTrials.gov registry entry for NCT00124137 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nuwellis, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Aquadex system is the first listed.
NCT00124137 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00124137 about?
NCT00124137 is a clinical study titled "Ultrafiltration Versus Intravenous (IV) Diuretics for Patients Hospitalized for Acute Decompensated Heart Failure: (UNLOAD)". The purpose of this study is to compare patients who are suffering from heart failure and who are fluid overloaded to determine if ultrafiltration (UF) can remove more of the extra fluid as measured by weight loss while in the hospital and improve the patient's breathing.
What is the current status of trial NCT00124137?
This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2004-04. Estimated completion is 2005-10.
What interventions are being tested in trial NCT00124137?
The interventions under investigation include: Aquadex system (DEVICE), IV diuretic (DRUG).
Who is sponsoring clinical trial NCT00124137?
This trial is sponsored by Nuwellis, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.